Article Versions Notes

Duan S, Li X, Han J, Yang Y, Luo R, Cai Y, Li X, Zheng Q, Guo J, Liu R. Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses. Antioxidants. 2024; 13(3):256. https://doi.org/10.3390/antiox13030256

Duan, Shuni, Xin Li, Junsong Han, Yang Yang, Ranyi Luo, Yajie Cai, Xiaojiaoyang Li, Qi Zheng, Jincheng Guo, and Runping Liu. 2024. "Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses" Antioxidants 13, no. 3: 256. https://doi.org/10.3390/antiox13030256

Duan, S., Li, X., Han, J., Yang, Y., Luo, R., Cai, Y., Li, X., Zheng, Q., Guo, J., & Liu, R. (2024). Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses. Antioxidants, 13(3), 256. https://doi.org/10.3390/antiox13030256